Myriad Genetics (MYGN) Plunges 1.88% After Guggenheim Downgrade

Generated by AI AgentAinvest Movers Radar
Wednesday, Apr 23, 2025 6:26 pm ET1min read

Myriad Genetics (MYGN) shares fell 1.88% today, reaching their lowest level since September 1998, with an intraday decline of 2.15%.

Guggenheim recently downgraded

from a "buy" rating to a "neutral" rating in a research report released on April 11, 2025. This change in rating is likely to have contributed to the recent decline in the company's stock price. The downgrade suggests that analysts at Guggenheim may have concerns about the company's future prospects or its ability to meet market expectations.

Comments



Add a public comment...
No comments

No comments yet